Log In
BCIQ
Print this Print this
 

IMM-272

  Manage Alerts
Collapse Summary General Information
Company Immuron Ltd.
DescriptionOrally delivered, bovine colostrum powder (BCP) against human rotaviruses
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationRotavirus
Indication DetailsTreat rotavirus diarrhea
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today